Sponsor:
QuantumLeap Healthcare Collaborative
Code:
NCT01042379
Conditions
Breast Neoplasms
Breast Cancer
Breast Tumors
Angiosarcoma
TNBC - Triple-Negative Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Standard Therapy
AMG 386 with or without Trastuzumab
AMG 479 (Ganitumab) plus Metformin
MK-2206 with or without Trastuzumab
AMG 386 and Trastuzumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-04. This information was provided to ClinicalTrials.gov by QuantumLeap Healthcare Collaborative on 2025-08-06.